Beijing Hongling Zhihe Medical Technology Co., Ltd. — driven by a mission to advance medical innovation across China.
Beijing Hongling Zhihe Medical Technology Co., Ltd. (HLZHMED) is a professional medical technology enterprise established and operating in Huairou District, Beijing, China.
We are dedicated to bridging the gap between advanced medical science and practical healthcare applications. Our multidisciplinary team brings together expertise in biomedical engineering, clinical research, technology consulting, and device distribution.
From healthcare IT system development to pioneering stem cell and gene therapy research, HLZHMED offers a comprehensive suite of services designed to support medical institutions, research organizations, and healthcare enterprises in China and beyond.
Our mission is to develop, transfer, and apply medical technologies that improve patient outcomes, support healthcare professionals, and advance the frontiers of biomedical science.
We envision a future where every person has access to advanced, technology-driven healthcare — from precision gene diagnostics to regenerative stem cell therapies.
We uphold the highest standards of scientific rigor and medical ethics, working collaboratively with partners across research, clinical practice, and industry.
We pursue the highest standards in every research project, technology solution, and client engagement.
We operate with full transparency and ethical responsibility — in research, commerce, and every client relationship.
We believe the best medical advances come through partnership — with institutions, researchers, and clients.
We embrace emerging technologies and continuously invest in novel approaches to medical challenges.
HLZHMED is headquartered in Huairou District, Beijing — an area increasingly recognized as a hub for life sciences and medical innovation.
Our location gives us close proximity to Beijing's leading hospitals, research universities, and the national regulatory bodies that govern medical technology in China.